Clinical Trials in Bucheon-si, Gyeonggido
4 recruiting
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Atopic Dermatitis
AbbVie200 enrolled124 locationsNCT06389136
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis
AbbVie675 enrolled148 locationsNCT06461897
Recruiting
Phase 2
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co. LTD.102 enrolled30 locationsNCT05389215
Recruiting
Phase 4
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI
Myocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity
Kiyuk Chang, MD,PhD3,548 enrolled7 locationsNCT04499859